prednisone has been researched along with Myelomonocytic Leukemia, Chronic in 8 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Meng, J | 1 |
Chen, L | 1 |
Hou, J | 1 |
Chi, H | 1 |
Wang, Z | 1 |
Yang, C | 1 |
Su, Y | 1 |
Hilmi, M | 1 |
Bally, C | 1 |
Burns, R | 1 |
Lorillon, G | 1 |
Bergeron, A | 1 |
Fenaux, P | 2 |
Ades, L | 1 |
Fain, O | 1 |
Gérin, M | 1 |
Bibi-Triki, T | 1 |
Braun, T | 1 |
Rodriguez, V | 1 |
Anderson, PM | 1 |
Trotz, BA | 1 |
Arndt, CA | 1 |
Allen, JA | 1 |
Khan, SP | 1 |
Harris, NL | 1 |
Demirjian, Z | 1 |
Heyll, A | 1 |
Derigs, G | 1 |
López-Guillermo, A | 2 |
Cervantes, F | 2 |
Sacanella, E | 1 |
Florensa, L | 2 |
Rozman, C | 2 |
Ribera, JM | 1 |
Feliu, E | 1 |
2 reviews available for prednisone and Myelomonocytic Leukemia, Chronic
Article | Year |
---|---|
Probable catastrophic antiphospholipid syndrome secondary to chronic myelomonocytic leukaemia in an adult patient and a mini review.
Topics: Antiphospholipid Syndrome; Bone Marrow; Computed Tomography Angiography; Humans; Hydroxychloroquine; | 2020 |
Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut.
Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; A | 2007 |
6 other studies available for prednisone and Myelomonocytic Leukemia, Chronic
Article | Year |
---|---|
Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Combined Modality Therapy; Drug Resistance; Humans; Hy | 2018 |
[Relapsing polychondritis and chronic myelomonocytic leukemia].
Topics: Blast Crisis; Glucocorticoids; Humans; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Polycho | 2009 |
Plasmacytoid T-zone cell proliferation in a patient with chronic myelomonocytic leukemia. Histologic and immunohistologic characterization.
Topics: Antibodies, Monoclonal; Antigens, CD; Bone Marrow; Cell Transformation, Neoplastic; Female; Humans; | 1991 |
Chronic myelomonocytic leukemia: clinical data, morphological features, and outcome in 56 patients.
Topics: Biomarkers, Tumor; Blast Crisis; Bone Marrow; Cytarabine; Germany, West; Hemorrhage; Humans; Leukemi | 1990 |
Pure red cell aplasia associated with chronic myelomonocytic leukaemia.
Topics: Aged; Blood Transfusion; Cyclophosphamide; Humans; Leukemia, Myelomonocytic, Chronic; Male; Mercapto | 1989 |
[Erythroblastopenia associated with chronic myelomonocytic leukemia].
Topics: Aged; Anemia; Bone Marrow; Erythroblasts; Humans; Leukemia, Myelomonocytic, Chronic; Male; Mercaptop | 1989 |